Glass Pipes and Bongs

The Court's majority concluded that medical cannabis does not meet the statutory definition of an "illegal drug." The post Oklahoma: Medical Cannabis Use While Pregnant Doesn’t Constitute Child Neglect, Appellate Court Rules appeared first on NORML. Go to the article

Cannabis decriminalization will "help address systemic inequities and promote treatment-focused alternatives to criminal penalties for substance use disorders," the ACP resolved. The post Physicians Group Calls for Cannabis Decriminalization appeared first on NORML. Go to the article

"The US federal government has thus far been unwilling to revise federal immigration law to match current public sentiment on drugs," the study's authors concluded. The post Analysis: Nearly 50,000 People Have Been Deported for Violating Marijuana Laws appeared first on NORML. Go to the article

Overall, current cannabis consumers possessed 42 percent lower odds of suffering from metabolic syndrome. The post Study: Cannabis Use Inversely Associated With Metabolic Syndrome in Younger Adults appeared first on NORML. Go to the article

"The present study represents the first human clinical trial to examine the acute effects of CBG on anxiety, stress, and mood." The post Clinical Trial: Hemp-Derived CBG Associated With Decreased Stress, Improved Memory appeared first on NORML. Go to the article

On behalf of over 500 member-businesses NCIA has submitted extensive public comment to the Department of Justice in support of the proposed rule to reclassify marijuana from Schedule I to Schedule III in the Controlled Substances Act. We are calling on the DEA reschedule, without delay and to issue guidance to federal agencies to ensure state-based cannabis programs are not disrupted by inappropriate federal enforcement. Download our full comments here. Moving cannabis to Schedule III would be a Go to the article

While there’s a lot more science involved in the cannabis industry today than back when folks were growing in closets or on hidden hillsides, none of that science has focused on the end user.  We know how to increase yield and cannabinoid production, for example, but there hasn’t been any real research done on how cultivation techniques or delivery methods affect the smokeability of the product from the consumer standpoint.  Until now, that is.  The cannabis industry is entering a new era of sci Go to the article

Over 90 percent of consumers said that cannabis was either “very,” “somewhat,” or “slightly” effective at managing their pain, improving their sleep, and reducing anxiety-related symptoms. The post Survey: Patients Say Cannabis Effectively Treats Their Musculoskeletal Pain appeared first on NORML. Go to the article

"[N]either young age of onset of cannabis use nor high-frequency use of cannabis or the preferred type of cannabis was associated with cannabis-associated psychotic symptoms." The post Meta-Analysis: Cannabis-Induced Psychosis Rare in Those Without Pre-Existing Mental Health Conditions appeared first on NORML. Go to the article

Investigators concluded, "Results at the user level of analysis showed that the majority of users experienced positive relief outcomes." The post Study: Consumers Report Improvements in Anxiety, Depression Following Cannabis Use appeared first on NORML. Go to the article

Investigators reported no link between cannabis exposure and ASD after controlling for relevant covariates, particularly tobacco consumption. The post Prenatal Cannabis Exposure Not Associated With Elevated Risk of Autism appeared first on NORML. Go to the article

"The rescheduling of marijuana from Schedule I to Schedule III … would not alter DOT's marijuana testing requirements," Transportation Secretary Pete Buttigieg told Congress. The post Transportation Secretary Affirms Reclassifying Marijuana Won’t Immediately Change Federal Drug Testing Standards appeared first on NORML. Go to the article

Patients consistently reported improvements in anxiety, pain, and sleep during the length of the study. The post Study: Patients With Inflammatory Arthritis Report Sustained Relief From Cannabis appeared first on NORML. Go to the article

Two-thirds of parents reported improvements in their child's behavior in six of the 12 categories assessed. The post Study: CBD-Rich Extracts Mitigate Symptoms in Adolescents With Autism appeared first on NORML. Go to the article

Last year, Management Science Associates (MSA) partnered with Vireo Health of Minnesota to complete a first of its kind study that sought to analyze the relationship between opioid reduction and cannabis consumption (you can find more information on those findings in our previous post). More recently, MSA has been exploring the impact of cannabis on sleep medication use. An estimated 30% of adults experience symptoms of insomnia, which can include difficulty falling asleep, staying asleep, or wa Go to the article